x Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials Open access logo PDF logo

Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, Lobello K, Li D, McRae T, Lucas P, Evans I, Booth K, Luscan G, Wyman BT, Hua LS, Yang LF, Brashear HR, Black RS

Alzheimer's Research & Therapy Volume 8, Issue 1, DOI: 10.1186/s13195-016-0189-7

  • 3 tweets
  • 1 news
  • 60 Mendeley readers

Timeline


Generating chart...


News

      Site data sourced from Altmetric.com and CSC (VIRTA)